In-vitro Toxicology Testing Market Size

In-vitro Toxicology Testing Market Size

In-vitro Toxicology Testing Market size reached over USD 1.8 billion in 2023 and is anticipated to register 7.7% CAGR between 2024 and 2032, due to the rising collaboration and partnerships for driving innovation and growth.

To get key market trends

  Download Free Sample

Leading industry players are joining forces with academic institutions and research organizations to develop advanced testing methodologies and technologies. These collaborations are aimed towards enhancing the accuracy and efficiency of toxicity screening processes for ensuring safer pharmaceutical and chemical product development.
 

These partnerships will continue to foster the development of novel solutions that meet the evolving regulatory requirements and industry needs to ultimately improve public health and safety standards. For instance, in February 2024, Danaher Corporation initiated a strategic collaboration with Cincinnati Children's Hospital Medical Center for focusing on in-vitro toxicology testing. This multi-year partnership aims to enhance patient safety by improving liver organoid technology for drug toxicity screening, potentially saving billions in research productivity.

The cosmetics industry is experiencing a surge in demand due to the ban on animal testing for cosmetics in regions, such as the European Union. This trend is driving cosmetic companies to adopt in-vitro toxicology tests to ensure product safety and compliance with regulations. Lately, more regions are implementing bans on animal testing and necessitating the use of alternative testing methods, such as in-vitro assays.
 

Consequently, the cosmetics industry is increasingly relying on this testing method to meet the regulatory requirements and consumer expectations for cruelty-free products. For instance, in March 2023, local biotech start-up Revivo BioSystems launched a cosmetics testing platform replicating blood flow under the skin. This innovation is encouraging companies to shift from animal testing for aligning with advancements in in-vitro testing methodologies.
 

However, the lack of expertise and the complexity of biological systems may hinder the market growth to some extent. Researchers are continuously grappling with understanding and navigating intricate biological processes. Addressing this challenge would involve training and advancements in technology to enhance expertise and simplify the interpretation of complex biological responses.